Table 4:
Linear regression:
predictors of increased LVEF.
|
Variable |
Coefficient |
CI
95% |
P |
|
Number
of sessions |
-0.04 |
(-0.29)-0.21 |
0.75 |
|
Trombolisis |
-0.76 |
(-3.92)-2.40 |
0.63 |
|
Ivrabadine |
2.10 |
(-2.98)-7.19 |
0.41 |
|
Diabetes
Mellitus |
-1.32 |
(-4.69)-2.05 |
0.44 |
|
Age |
0.07 |
(-0.08)-0.23 |
0.36 |
|
Smoking |
1.15 |
(-1.86)-4.17 |
0.45 |
|
Hypertension |
1.31 |
(-1.29)-3.92 |
0.32 |
|
Eplerenone |
1.78 |
(-1.39)-4.97 |
0.27 |
|
Asynergy post CRP |
-1.51 |
(-4.34)-1.32 |
0.29 |
|
Gender |
-1.99 |
(-5.96)-1.97 |
0.32 |
|
High/Moderate
risk |
5.80 |
3.13-8.47 |
0.00 |
|
Number
of vessels |
-2.57 |
(-4.74)-(-0.39) |
0.02 |
|
Coronary
reperfusion Conventional
stent (ref.) Drug-eluting
stent Combination
stents Surgery |
-0.51 4.39 -2.27 |
(-3.49)
-2.47 0.51
-8.27 (-9.52)-4.99 |
0.73 0.03 0.53 |